Surrozen Inc Warrant (SRZNW)

• Market cap: $47.5K
• 1 day: 0%
• 5 days: -23.71%
• 1 month: 23.33%
• 3 months: -33.03%
• 6 months: -43.94%
• Year to date: -54.46%
• 1 year: -39.59%
• 5 years: -99.2%
• 10 years: -99.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).

Employees: 41